Evidence map›Paper›PMID 26100017›Full record

ArticleMolecular and cellular biology2015

RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.

Philip J Uren, Dat T Vo, Patricia Rosa de Araujo, Rebecca Pötschke, Suzanne C Burns, Emad Bahrami-Samani, Mei Qiao, Raquel de Sousa Abreu, Helder I Nakaya, Bruna R Correa and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Philip J UrenMolecular and Computational Biology Section, Division of Biological Sciences, University of Southern California, Los Angeles, California, USA.
Dat T VoChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Patricia Rosa de AraujoChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Rebecca PötschkeUniversity Medical Center, Department of Children's Hospital, Halle (Saale), Germany.
Suzanne C BurnsChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Emad Bahrami-SamaniMolecular and Computational Biology Section, Division of Biological Sciences, University of Southern California, Los Angeles, California, USA.
Mei QiaoChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Raquel de Sousa AbreuChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Helder I NakayaSchool of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil Department of Pathology, Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, Georgia, USA.
Bruna R CorreaChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Caspar KühnölUniversity Medical Center, Department of Children's Hospital, Halle (Saale), Germany.
Jernej UleDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom.
Jennifer L MartindaleLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Kotb AbdelmohsenLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Myriam GorospeLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Andrew D SmithMolecular and Computational Biology Section, Division of Biological Sciences, University of Southern California, Los Angeles, California, USA andrewds@usc.edu penalva@uthscsa.edu.
Luiz O F PenalvaChildren's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA andrewds@usc.edu penalva@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · USUniversity of Southern California · USNational Institutes of Health · USEmory National Primate Research CenterInstitute on Aging · USUniversity College London · GB

Funding

Post-transcriptional Regulation Of Proliferative and Stress Response GenesZIAAG000511 · NIA · NATIONAL INSTITUTE ON AGING · PI GOROSPE, MYRIAM · 2009 to 2025
$25.4M
RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative PathologiesZIAAG000518 · NIA · NATIONAL INSTITUTE ON AGING · PI GOROSPE, MYRIAM · 2009 to 2025
$11.6M
Computational Methods for Deep Sequencing Based RBP Binding Motif CharacterizatioR01HG006015 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PENALVA, LUIZ OTAVIO, SMITH, ANDREW DAVID · 2011 to 2017
$2.6M
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cellsR21CA175875 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAKANO, ICHIRO, PENALVA, LUIZ OTAVIO · 2014 to 2015
$377k
NCI NIH HHS 1R21CA175875-01A1NCI NIH HHS R21 CA175875NHGRI NIH HHS R01 HG006015NHGRI NIH HHS R01HG006015
6 · The paper itself

Abstract

The conserved RNA-binding protein Musashi1 (MSI1) has emerged as a key oncogenic factor in numerous solid tumors, including glioblastoma. However, its mechanism of action has not yet been established comprehensively. To identify its target genes comprehensively and determine the main routes by which it influences glioblastoma phenotypes, we conducted individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP) experiments. We confirmed that MSI1 has a preference for UAG sequences contained in a particular structural context, especially in 3' untranslated regions. Although numerous binding sites were also identified in intronic sequences, our RNA transcriptome sequencing analysis does not favor the idea that MSI1 is a major regulator of splicing in glioblastoma cells. MSI1 target mRNAs encode proteins that function in multiple pathways of cell proliferation and cell adhesion. Since these associations indicate potentially new roles for MSI1, we investigated its impact on glioblastoma cell adhesion, morphology, migration, and invasion. These processes are known to underpin the spread and relapse of glioblastoma, in contrast to other tumors where metastasis is the main driver of recurrence and progression.

Indexed as

3' Untranslated RegionsAlternative SplicingBase SequenceBinding SitesCell AdhesionCell Line, TumorCell MovementCell ProliferationCell SurvivalGlioblastomaHumansNeoplasm InvasivenessNerve Tissue ProteinsRNA-Binding ProteinsRNA InterferenceRNA, Small Interfering3' Untranslated RegionsMSI1 protein, humanNerve Tissue ProteinsRNA-Binding ProteinsRNA, Small Interfering

Identifiers

PMID26100017
PMCPMC4525321
OpenAlexW1926743275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.